Paced by Dx Segment, BD's Q2 Sales Rise 7 Percent

BD Diagnostics' revenues climbed 9 percent, helping drive the firm's overall revenues up 7 percent for the quarter.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories